HGA found money-saving solutions for rapidly changing compounding pharmacy standards.
This is an excerpt from an article in Medical Construction & Design.
The latest version of USP <800> was released December 1, 2019, which didn’t give a certain Midwest client much time to get pharmacies at four different hospitals up to compliance with both USP <797> & <800> by the end of the year. Temporary pharmacies were needed to comply with the looming timeline and to ensure no interruption of Compounding Sterile Preparations (CSP), the drugs that are mixed from different sterile compounds for patients.
At first, temporary pharmacies were costly and over-budget, and in some cases more expensive than the alterations for compliance at the permanent pharmacy. Challenged by the client to come up with a cost-saving alternative, HGA’s design team used Segregated Compounding Areas (SCA) as a substitute to the common Clean Room pharmacy configuration. Many of these temporary pharmacies were not going to be in operation for long, so providing a safe, quick, and cost-effective solution was key. SCA’s were able to be employed because the hospital was able to use the drug within 12 hours of it being made, known as the Beyond Use Date (BUD). In fact, many of the Hazardous Drugs (HD) being compounded are for cancer patients and fall well within the BUD requirement of 12 hours or less.
To learn more about Compounding Pharmacy solutions, visit Medical Construction & Design.
About the Author
Jesse Robinson is a Senior Medical Planner at HGA in Milwaukee.